Oscillometry Market is expected to reach US$ 242.66 Million by 2031

Device Oscillometry Product Segment Drives Oscillometry Market Growth    

According to our new research study named "Oscillometry Market Forecast to 2031 – Global Analysis – by Product Type, Drug Type, Indication, Manufacturing Type, and Distribution Channel," the market was valued at US$ 168.30 Million in 2024 and is projected to reach US$ 242.66 Million by 2031; it is expected to register a CAGR of 5.5% during 2025–2031. The growing burden of respiratory diseases such as asthma and COPD, as well as increasing technological advancements and rising regulatory support for home monitoring, are driving the oscillometry market size. However, the Lack of Standardization and Clinical Interpretation Consistency and Limited Accessibility in Low- and Middle-Income Countries hinder oscillometry market growth. The Clinical Emphasis on Small Airway Dysfunction (SAD) Detection is projected to bring new oscillometry market trends in the coming years.         

The growing burden of respiratory diseases such as asthma and COPD drives the global oscillometry market, particularly impulse oscillometry (IOS), by providing effort-independent lung function assessment for diagnosis and monitoring in vulnerable populations. According to the WHO, COPD caused 3.72 million deaths in 2021, with prevalence projected to rise due to aging and smoking. In 2023, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) report emphasized IOS for small airway detection in COPD. For asthma, the WHO's 2023 fact sheet estimated 365 million cases globally, with IOS aiding in pediatric and elderly assessment. In Europe, the European Respiratory Society's 2023 guidelines recommended IOS for asthma-COPD overlap syndrome. New product developments include EMA's 2023–2024 authorizations for portable IOS devices in respiratory diagnostics. The WHO's 2024 updates on chronic respiratory diseases noted IOS utility in low-resource settings for nonspirometry alternatives. These developments support oscillometry's expansion in managing rising respiratory morbidity through precise, patient-friendly testing.  

Oscillometry Market, by Region, 2024 (%)

Source: The Insight Partners Analysis

Oscillometry Market Analysis Based on Segmental Evaluation:

• Based on product, the oscillometry market is bifurcated into devices and accessories. The device segment held a larger oscillometry market share in 2024. The device segment dominated the oscillometry market in 2024, driven by widespread clinical adoption, technological advancements, higher diagnostic accuracy, and growing demand for standalone, integrated respiratory assessment systems globally. Accessories comprise filters, nose clips, support arms, and other accessories. 
• By technology, the oscillometry market includes impulse oscillometry, the forced oscillation technique, and hybrid devices. In 2024, impulse oscillometry had the largest market share as it is noninvasive, requires little patient cooperation, works well for children, and is increasingly used in routine lung diagnostics worldwide.
• In terms of application, the oscillometry market is divided into asthma, COPD, and other uses. In 2024, asthma was the leading segment, driven by more asthma cases, the need for early airway detection, benefits for pediatric assessment, and frequent monitoring in clinical settings.
• By end user, the oscillometry market is divided into hospitals, diagnostic labs, and others. Hospitals made up a large part of the market in 2024 because they have better equipment, trained staff, see more patients, offer full breathing tests, and are using new breathing test technology more often around the world.

The geographical scope of the oscillometry market report includes the assessment of market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America dominated the largest oscillometry market share in 2024. Advanced healthcare infrastructure, high adoption of pulmonary diagnostics, and rising prevalence of respiratory disorders drive demand. The US leads through strong clinical adoption, technological innovation, and remote monitoring integration. Canada benefits from expanding respiratory care services and supportive regulations. Mexico supports growth via improving healthcare access and diagnostic investments, creating a well-connected ecosystem advancing oscillometry adoption.

Morgan Scientific Inc; Chest MI Inc; MGC Diagnostics Corp; Vitalograph Ltd; COSMED Srl; THORASYS Thoracic Medical Systems Inc.; Jaeger Medical GmbH; Cognita Labs, LLC; IngMar Medical; GANSHORN Medizin Electronic GmbH; Lothar Medical GmbH are among the leading companies profiled in the oscillometry market report.  

Based on product, the oscillometry market is bifurcated into devices and accessories. Accessories comprise filters, nose clips, support arms, and other accessories. Based on technology, the oscillometry market is divided into Impulse oscillometry, forced oscillation technique, and hybrid oscillometry devices. Based on application, the oscillometry market is segmented into asthma, COPD, and others. Based on end user, the oscillometry market is segmented into hospitals, diagnostic laboratories, and others. Geographically, the market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).  

Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com